Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) marketplace, to enhance data-driven ...
An op-ed published by MedPage Today in 2023 that called for more aggressive enforcement of the data reporting law said the ...
The Food and Drug Administration will announce on Monday that it has sent over 2,200 letters pressing drug manufacturers, ...
An FDA review of records in the U.S. clinical trials database shows that results have not been reported for 30% of clinical ...
PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...
Endpoint Clinical today announced the release of Elosity® R3, a major update to its next-generation Randomization and Trial Supply Management (RTSM) platform. The new release introduces expanded ...
U.S. Food and Drug Administration (FDA) guidance states that payment for participation in clinical trials must be just, fair, and receive approval from an institutional review board (IRB). According ...
Many researchers prefer the “live” data that comes from real-world results while still acknowledging potential shortcomings.
An AI study analyzing more than 400,000 Reddit posts identified patient-reported symptoms associated with GLP-1 medications ...
Ocugen Inc. (NASDAQ:OCGN) is one of the 10 best penny stocks that could triple your money. On March 24, Ocugen Inc. (NASDAQ:OCGN) announced 12-month data from the Phase 2 ArMaDa clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results